去甲肾上腺素盐制剂并非药效问题。 - Suppr

Suppr

超能文献

Norepinephrine salt formulations are not a matter of pharmacologic potency.

作者信息

Wieruszewski Patrick M, Khanna Ashish K

机构信息

Department of Pharmacy, Mayo Clinic, RO_MB_GR_722PH, 200 First Street SW, Rochester, MN, 55905, USA.

Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.

出版信息

Intensive Care Med. 2024 Jul;50(7):1179-1180. doi: 10.1007/s00134-024-07451-2. Epub 2024 May 2.

DOI:10.1007/s00134-024-07451-2

PMID:38695929

Abstract

摘要

相似文献

Norepinephrine salt formulations are not a matter of pharmacologic potency.

Intensive Care Med. 2024 Jul;50(7):1179-1180. doi: 10.1007/s00134-024-07451-2. Epub 2024 May 2.

Norepinephrine in septic shock.

Intensive Care Med. 2019 May;45(5):687-689. doi: 10.1007/s00134-018-5499-8. Epub 2019 Jan 10.

Comment on "A comparison of epinephrine and norepinephrine in critically Ill patients".

Intensive Care Med. 2009 Jul;35(7):1310; author reply 1311. doi: 10.1007/s00134-009-1492-6. Epub 2009 Apr 15.

Acute renal failure and sepsis.

N Engl J Med. 2004 Nov 25;351(22):2347-9; author reply 2347-9. doi: 10.1056/NEJM200411253512224.

Vassopressors and inotropes.

Med Lett Drugs Ther. 2011 Nov 14;53(1377):90-2.

Evaluation of the pharmacologic basis for the therapy of circulatory shock.

Am J Cardiol. 1970 Dec;26(6):570-7. doi: 10.1016/0002-9149(70)90409-1.

Arginine vasopressin in advanced vasodilatory shock.

Circulation. 2003 Nov 11;108(19):e142; author reply e142. doi: 10.1161/01.CIR.0000099845.53469.EA.

To drink or not to drink: The role of fluid versus vasopressor resuscitation in traumatic brain injury and systemic inflammatory response syndrome.

Crit Care Med. 2006 Oct;34(10):2697-8. doi: 10.1097/01.CCM.0000243975.53041.4f.

Influence of vasoexcitor-pressor drugs on microvascular injury in shock.

Bibl Anat. 1967;9:33-7.

Vasopressor Effects on Cerebral Microcirculation: Reply.

Anesthesiology. 2022 May 1;136(5):868. doi: 10.1097/ALN.0000000000004150.

引用本文的文献

Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations.

Intensive Care Med. 2025 Sep;51(9):1664-1673. doi: 10.1007/s00134-025-08053-2. Epub 2025 Jul 29.

Norepinephrine dose reporting: are we looking at different sides of the same coin?

Intensive Care Med. 2024 Jul;50(7):1181-1182. doi: 10.1007/s00134-024-07487-4. Epub 2024 May 22.

本文引用的文献

Norepinephrine dose reporting: are we looking at different sides of the same coin?

Intensive Care Med. 2024 Jul;50(7):1181-1182. doi: 10.1007/s00134-024-07487-4. Epub 2024 May 22.

Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force.

Crit Care Med. 2024 Apr 1;52(4):521-530. doi: 10.1097/CCM.0000000000006176. Epub 2024 Jan 19.

Norepinephrine dosage: the details go beyond a grain of salt.

Intensive Care Med. 2023 Jun;49(6):714-715. doi: 10.1007/s00134-023-07077-w. Epub 2023 May 6.

Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study.

Anesthesiology. 2014 Nov;121(5):930-6. doi: 10.1097/ALN.0000000000000430.

Defining and characterizing drug/compound function.

Biochem Pharmacol. 2014 Jan 1;87(1):40-63. doi: 10.1016/j.bcp.2013.07.033. Epub 2013 Aug 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Norepinephrine salt formulations are not a matter of pharmacologic potency.

Intensive Care Med. 2024 Jul;50(7):1179-1180. doi: 10.1007/s00134-024-07451-2. Epub 2024 May 2.

Norepinephrine in septic shock.

Intensive Care Med. 2019 May;45(5):687-689. doi: 10.1007/s00134-018-5499-8. Epub 2019 Jan 10.

Comment on "A comparison of epinephrine and norepinephrine in critically Ill patients".

Intensive Care Med. 2009 Jul;35(7):1310; author reply 1311. doi: 10.1007/s00134-009-1492-6. Epub 2009 Apr 15.

Acute renal failure and sepsis.

N Engl J Med. 2004 Nov 25;351(22):2347-9; author reply 2347-9. doi: 10.1056/NEJM200411253512224.

Vassopressors and inotropes.

Med Lett Drugs Ther. 2011 Nov 14;53(1377):90-2.

Evaluation of the pharmacologic basis for the therapy of circulatory shock.

Am J Cardiol. 1970 Dec;26(6):570-7. doi: 10.1016/0002-9149(70)90409-1.

Arginine vasopressin in advanced vasodilatory shock.

Circulation. 2003 Nov 11;108(19):e142; author reply e142. doi: 10.1161/01.CIR.0000099845.53469.EA.

To drink or not to drink: The role of fluid versus vasopressor resuscitation in traumatic brain injury and systemic inflammatory response syndrome.

Crit Care Med. 2006 Oct;34(10):2697-8. doi: 10.1097/01.CCM.0000243975.53041.4f.

Influence of vasoexcitor-pressor drugs on microvascular injury in shock.

Bibl Anat. 1967;9:33-7.

Vasopressor Effects on Cerebral Microcirculation: Reply.

Anesthesiology. 2022 May 1;136(5):868. doi: 10.1097/ALN.0000000000004150.

引用本文的文献

Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations.

Intensive Care Med. 2025 Sep;51(9):1664-1673. doi: 10.1007/s00134-025-08053-2. Epub 2025 Jul 29.

Norepinephrine dose reporting: are we looking at different sides of the same coin?

Intensive Care Med. 2024 Jul;50(7):1181-1182. doi: 10.1007/s00134-024-07487-4. Epub 2024 May 22.

本文引用的文献

Norepinephrine dose reporting: are we looking at different sides of the same coin?

Intensive Care Med. 2024 Jul;50(7):1181-1182. doi: 10.1007/s00134-024-07487-4. Epub 2024 May 22.

Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force.

Crit Care Med. 2024 Apr 1;52(4):521-530. doi: 10.1097/CCM.0000000000006176. Epub 2024 Jan 19.

Norepinephrine dosage: the details go beyond a grain of salt.

Intensive Care Med. 2023 Jun;49(6):714-715. doi: 10.1007/s00134-023-07077-w. Epub 2023 May 6.

Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study.

Anesthesiology. 2014 Nov;121(5):930-6. doi: 10.1097/ALN.0000000000000430.

Defining and characterizing drug/compound function.

Biochem Pharmacol. 2014 Jan 1;87(1):40-63. doi: 10.1016/j.bcp.2013.07.033. Epub 2013 Aug 15.